{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:55:19Z","timestamp":1788893719983,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:p>Rejection surveillance after heart transplantation has traditionally relied on numerous endomyocardial biopsies, most of which occur during the first posttransplant year. With the introduction of gene expression profiling and, more recently, donor-derived cell-free DNA, a great proportion of surveillance is being performed noninvasively with both tests. Although patients have welcomed the use of paired testing because of the decreased risk and inconvenience, interpretation of both tests can sometimes be challenging, particularly when the test results are discordant. Growing evidence from both single-center experiences and large national databases has given insights that have allowed the field to operationalize dual testing and provide physicians with algorithms to approach paired testing. The increased use of noninvasive testing has also begun to challenge the role of biopsy as the gold standard for graft monitoring, not only for rejection but over the life of the heart transplant. In a growing number of circumstances, cell-free DNA not only may be a better means of assessing rejection but could also redefine how clinicians approach the diagnosis and even treatment of graft injury. As the heart transplant community garners more experience and generates more data, the current paradigms of heart transplant surveillance will continue to be challenged.<\/jats:p>","DOI":"10.1097\/tp.0000000000005113","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T04:00:51Z","timestamp":1719806451000},"page":"285-291","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Rejection Surveillance After Heart Transplantation: Is Paired Noninvasive Testing the New Gold Standard?"],"prefix":"10.1097","volume":"109","author":[{"given":"Yasbanoo","family":"Moayedi","sequence":"first","affiliation":[{"name":"Ted Rogers Centre for Heart Research, Ajmera Transplant Centre, University of Toronto, Toronto, ON, Canada."},{"name":"Ajmera Transplant Centre, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Teuteberg","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine, Stanford University, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"R1-20250124","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.healun.2007.05.017","article-title":"Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation through Gene Expression (IMAGE) trial.","volume":"26","author":"Pham","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R2-20250124","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMoa0912965","article-title":"Gene-expression profiling for rejection surveillance after cardiac transplantation.","volume":"362","author":"Pham","year":"2010","journal-title":"N Engl J Med"},{"key":"R3-20250124","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cjco.2022.02.002","article-title":"Sparing the Prod: providing an alternative to endomyocardial biopsies with noninvasive surveillance after heart transplantation during COVID-19.","volume":"4","author":"Amadio","year":"2022","journal-title":"CJC Open"},{"key":"R4-20250124","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients.","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R5-20250124","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/eurheartj\/ehv682","article-title":"Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II.","volume":"37","author":"Crespo-Leiro","year":"2016","journal-title":"Eur Heart J"},{"key":"R6-20250124","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients.","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R7-20250124","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jchf.2022.11.002","article-title":"The end of endomyocardial biopsy? A practical guide for noninvasive heart transplant rejection surveillance.","volume":"11","author":"Holzhauser","year":"2023","journal-title":"JACC Heart Fail"},{"key":"R8-20250124","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2217\/bmm-2021-0968","article-title":"Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches.","volume":"16","author":"Edwards","year":"2022","journal-title":"Biomark Med"},{"key":"R9-20250124","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ajt.2023.02.025","article-title":"The evolving use of biomarkers in heart transplantation: Consensus of an expert panel.","volume":"23","author":"Kobashigawa","year":"2023","journal-title":"Am J Transplant"},{"key":"R10-20250124","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-6143.2005.01175.x","article-title":"Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling.","volume":"6","author":"Deng","year":"2006","journal-title":"Am J Transplant"},{"key":"R11-20250124","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/CIRCHEARTFAILURE.114.001658","article-title":"Randomized pilot trial of gene expression profiling versus heart biopsy in the first year after heart transplant: early invasive monitoring attenuation through gene expression trial.","volume":"8","author":"Kobashigawa","year":"2015","journal-title":"Circ Heart Fail"},{"key":"R12-20250124","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.healun.2018.09.004","article-title":"Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients.","volume":"38","author":"Moayedi","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R13-20250124","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.healun.2019.05.008","article-title":"Gene expression profiling and racial disparities in outcomes after heart transplantation.","volume":"38","author":"Moayedi","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R14-20250124","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.healun.2019.01.006","article-title":"Infectious complications after heart transplantation in patients screened with gene expression profiling.","volume":"38","author":"Moayedi","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R15-20250124","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics.","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat Med"},{"key":"R16-20250124","doi-asserted-by":"crossref","first-page":"241ra","DOI":"10.1126\/scitranslmed.3007803","article-title":"Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection.","volume":"6","author":"De Vlaminck","year":"2014","journal-title":"Sci Transl Med"},{"key":"R17-20250124","doi-asserted-by":"crossref","first-page":"e0227385","DOI":"10.1371\/journal.pone.0227385","article-title":"Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: validation of a rapid and highly sensitive clinical test for stratification of rejection probability.","volume":"15","author":"North","year":"2020","journal-title":"PLoS One"},{"key":"R18-20250124","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1111\/ajt.15339","article-title":"Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: a prospective multicenter study.","volume":"19","author":"Khush","year":"2019","journal-title":"Am J Transplant"},{"key":"R19-20250124","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/CIRCULATIONAHA.120.049098","article-title":"Cell-free DNA to detect heart allograft acute rejection.","volume":"143","author":"Agbor-Enoh","year":"2021","journal-title":"Circulation"},{"key":"R20-20250124","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.healun.2022.04.002","article-title":"A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation.","volume":"41","author":"Kim","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R21-20250124","doi-asserted-by":"crossref","first-page":"e14258","DOI":"10.1111\/ctr.14258","article-title":"Single-center utilization of donor-derived cell-free DNA testing in the management of heart transplant patients.","volume":"35","author":"Gondi","year":"2021","journal-title":"Clin Transplant"},{"key":"R22-20250124","doi-asserted-by":"crossref","first-page":"e14699","DOI":"10.1111\/ctr.14699","article-title":"Combining donor derived cell free DNA and gene expression profiling for non-invasive surveillance after heart transplantation.","volume":"37","author":"Henricksen","year":"2022","journal-title":"Clin Transplant"},{"key":"R23-20250124","doi-asserted-by":"crossref","first-page":"e14984","DOI":"10.1111\/ctr.14984","article-title":"Comparison of two donor-derived cell-free DNA tests and a blood gene-expression profile test in heart transplantation.","volume":"37","author":"Rodgers","year":"2023","journal-title":"Clin Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T14:01:33Z","timestamp":1737727293000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005113","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}